SC
AXNX

Sculptor Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Sculptor Capital’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,000
Closed -$281K – 382
2020
Q2 		$281K Hold
8,000
– – ﹤0.01% 236
2020
Q1 		$203K Buy
+8,000
New +$238K ﹤0.01% 201

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Sculptor Capital's AXNX Position: Q3 2020 in Review

Sculptor Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2020, closing a stake of 8,000 shares — an estimated $281K sold.

Sculptor Capital first reported a position in AXNX in Q1 2020 and held it in 2 quarters. The position peaked at $281K in Q2 2020. 151 funds tracked by Wall St. Rank hold AXNX as of Q3 2020.

  • Sculptor Capital reported no remaining Axonics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Sculptor Capital sold 8,000 Axonics, Inc. Common Stock shares in Q3 2020, an estimated $281K.
  • Sculptor Capital first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Sculptor Capital's Axonics, Inc. Common Stock position peaked at $281K in Q2 2020.
  • 151 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2020.

Based on Sculptor Capital's 13F filing for Q3 2020, filed 12 Nov 2020.